| Report ID | 283193 |
| Drug Identification Number | 02429063 |
| Brand name | VISTITAN |
| Common or Proper name | VISTITAN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | BIMATOPROST |
| Strength(s) | 0.03% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01EE |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2026-04-20 |
| Estimated end date | 2026-05-15 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-04-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-20 | French | Compare |
| v1 | 2026-04-20 | English | Compare |
Showing 1 to 2 of 2